Clinician Scientist Development Award supports early-career physician faculty with mentored Friedreich’s ataxia research and protected time to build independent clinician-scientist careers.
Funder: Friedreich's Ataxia Research Alliance
Due Dates: October 15, 2026 (Second-round application) | February 15, 2027 (First-round LOI) | April 15, 2027 (First-round application) | August 15, 2027 (Second-round LOI)
Funding Amounts: Up to $100,000 per year in direct costs for one or two years
Summary: Supports early-career physician faculty through mentored Friedreich’s ataxia research and protected time to develop independent clinician-scientist careers.
Key Information: Applicants must commit at least 50% effort, with a Department Chair letter confirming at least 50% protected time.
The Friedreich’s Ataxia Research Alliance (FARA) funds mentored clinical research and protected research time for early-career physician faculty developing independent clinician-scientist careers. The award supports clinicians building expertise in diagnosing, managing, or treating Friedreich’s ataxia (FA) while pursuing highly significant clinical or translational questions under an established FA expert’s mentorship.
Supported work includes patient-oriented research, natural history, epidemiologic and behavioral studies, clinical trials, disease mechanisms related to symptoms and progression, clinical outcome assessments, and biomarkers. Translational projects may develop treatments or improve diagnosis. Studies without human participants or human tissue may qualify when their primary goal is developing therapies, diagnostic tests, or tools to prevent or mitigate FA. Training and research leading to an MSCI, MPH, or equivalent degree are viewed favorably.